Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.

Reddy JA, Westrick E, Vlahov I, Howard SJ, Santhapuram HK, Leamon CP.

Cancer Chemother Pharmacol. 2006 Aug;58(2):229-36. Epub 2005 Dec 6.

PMID:
16331500
2.

Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates.

Austin CD, Wen X, Gazzard L, Nelson C, Scheller RH, Scales SJ.

Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17987-92. Epub 2005 Dec 1.

3.

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells.

Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, Fleming MD.

Nat Genet. 2005 Nov;37(11):1264-9. Epub 2005 Oct 16.

4.

Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic.

Leamon CP, Reddy JA, Vlahov IR, Vetzel M, Parker N, Nicoson JS, Xu LC, Westrick E.

Bioconjug Chem. 2005 Jul-Aug;16(4):803-11.

PMID:
16029021
5.

Small molecule toxins targeting tumor receptors.

Dyba M, Tarasova NI, Michejda CJ.

Curr Pharm Des. 2004;10(19):2311-34. Review.

PMID:
15279611
6.

Release from polymeric prodrugs: linkages and their degradation.

D'Souza AJ, Topp EM.

J Pharm Sci. 2004 Aug;93(8):1962-79. Review.

PMID:
15236447
7.

Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.

Paulos CM, Turk MJ, Breur GJ, Low PS.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1205-17. Review.

PMID:
15094216
8.

Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor.

Zhao XB, Lee RJ.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1193-204. Review.

PMID:
15094215
9.

Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.

Lu Y, Sega E, Leamon CP, Low PS.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1161-76. Review.

PMID:
15094213
10.

Folate-receptor-targeted radionuclide imaging agents.

Ke CY, Mathias CJ, Green MA.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1143-60. Review.

PMID:
15094212
11.

Folate receptor endocytosis and trafficking.

Sabharanjak S, Mayor S.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1099-109. Review.

PMID:
15094209
12.
13.

Folate receptor-targeted drugs for cancer and inflammatory diseases.

Low PS, Antony AC.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1055-8. Review. No abstract available.

PMID:
15094205
14.

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.

Giles F, Estey E, O'Brien S.

Cancer. 2003 Nov 15;98(10):2095-104. Review.

15.

Optical imaging of metastatic tumors using a folate-targeted fluorescent probe.

Kennedy MD, Jallad KN, Thompson DH, Ben-Amotz D, Low PS.

J Biomed Opt. 2003 Oct;8(4):636-41.

PMID:
14563201
16.

Evaluation of folate conjugate uptake and transport by the choroid plexus of mice.

Kennedy MD, Jallad KN, Lu J, Low PS, Ben-Amotz D.

Pharm Res. 2003 May;20(5):714-9.

PMID:
12751625
17.

Perspectives on anti-HER monoclonal antibodies.

Ranson M, Sliwkowski MX.

Oncology. 2002;63 Suppl 1:17-24. Review.

PMID:
12422051
18.

Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.

Ross S, Spencer SD, Holcomb I, Tan C, Hongo J, Devaux B, Rangell L, Keller GA, Schow P, Steeves RM, Lutz RJ, Frantz G, Hillan K, Peale F, Tobin P, Eberhard D, Rubin MA, Lasky LA, Koeppen H.

Cancer Res. 2002 May 1;62(9):2546-53.

19.
20.

Targeted drug conjugates: principles and progress.

Garnett MC.

Adv Drug Deliv Rev. 2001 Dec 17;53(2):171-216. Review.

PMID:
11731026
Items per page

Supplemental Content

Write to the Help Desk